0,1,2,3,4,5,6,7,8,9,10,11,12,13
Table I. Clinical characteristics of the 15 serum samples for iTRAQ testing.,,,,,,,,,,,,,
,,,Age,,,,,,AST,ALT,TBIL,PT,HBV DNA
No.,Source of serum,Gender,(years),HBsAg,HBsAb,HBeAg,HBeAb,HBcAb,(14.5‑40.0 U/l),,(3‑35 U/l)  (4.0‑23.9 µmol/l) (11.0‑14.5 sec),,(IU/ml)
1,Healthy control,Male,34,-,+,-,-,-,21.0,31,13.8,12.3,<100
2,Healthy control,Male,28,-,+,-,-,-,31.0,30,20.1,13.1,<100
3,Healthy control,Male,36,-,+,-,-,-,15.0,24,20.1,13.5,<100
4,Healthy control,Male,27,-,+,-,-,-,19.5,22,22.0,11.8,<100
5,Healthy control,Male,31,-,+,-,-,-,17.5,20,13.3,12.7,<100
6,CHB patient,Male,48,+,-,+,-,+,45.0,82,20.7,12.1,8.03x107
7,CHB patient,Male,28,+,-,+,-,+,38.0,84,22.4,14.1,1.76x106
8,CHB patient,Male,32,+,-,+,-,+,39.0,43,15.9,13.5,8.18x106
9,CHB patient,Male,24,+,-,+,-,+,36.0,38,21.6,12.9,1.02x106
10,CHB patient,Male,22,+,-,+,-,+,49.0,57,18.7,14.2,3.21x106
11,HBV-induced ACLF patient,Male,39,+,-,-,+,+,26.0,35,463.5,25.5,6.52x104
12,HBV-induced ACLF patient,Male,51,+,-,+,-,+,78.0,65,312.5,35.2,1.78x106
13,HBV-induced ACLF patient,Male,46,+,-,+,-,+,101.0,46,556.7,29.1,3.55x106
14,HBV-induced ACLF patient,Male,55,+,-,+,-,+,58.0,110,636.8,32.3,4.21x105
15,HBV-induced ACLF patient,Male,32,+,-,-,+,+,115.0,78,482.5,28.8,6.17x105
